Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
12/2003
12/17/2003CN1131224C Luteolin and method for preparationg luteolin derivatives
12/17/2003CN1131209C Alkyl dihalogenated phenyl-substituted ketoenols useful as. pesticides and herbicides
12/17/2003CN1131202C Calcium receptor-active compounds
12/16/2003US6664401 Reacting a isochroman-1,3-dione with a carbonyl compound whose carbonyl group is substituted with an acyl activating group, in the presence of a base and a solvent; use making anticancer agents for example
12/16/2003US6664382 Recovery of isoflavones from soy molasses
12/16/2003US6664288 Method and composition for the treatment of cancer
12/16/2003US6664272 Such as 1,5-Bis-(2, 4-difluorophenyl)penta-1,4-diene-3 -one; administering to inhibit tissue factor and vascular endothelial growth factor (VEGF) production in cancerous tissue
12/11/2003WO2003102140A2 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis
12/11/2003WO2003101950A2 Methods for enhancing motor performance and/or endurance
12/11/2003WO2003101933A1 Intermediate products, methods for their preparation and use thereof
12/11/2003WO2002087508A3 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
12/11/2003US20030229136 Anticancer agents; antiproliferative agents
12/11/2003US20030229097 Potentiation of fungicides
12/11/2003US20030229092 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens
12/11/2003US20030229065 Measuring drug resistance, calibration; reducing antibiotic resistance
12/11/2003US20030229058 Aryl aniline beta2 adrenergic receptor agonists
12/11/2003CA2488012A1 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis
12/11/2003CA2487659A1 Intermediate products, methods for their preparation and use thereof
12/11/2003CA2477261A1 Methods for enhancing motor performance and/or endurance
12/10/2003EP1369489A1 Flavonoid compound and process for producing the same
12/10/2003EP1368663A2 Novel reagents for detecting cannabinoids
12/10/2003EP1368305A1 7, 9-substituted tetracycline compounds
12/10/2003EP1368048A1 Pharmaceutical composition made of cannabis extracts
12/10/2003EP1368024A1 Treatment of restenosis
12/10/2003EP1228058B1 Benzopyranyl guanidine derivatives, process for preparation thereof, and pharmaceutical compositions containing them
12/10/2003EP1095032B1 Reagents for cyp2d fluorescent assay
12/10/2003EP0714396B1 Vasocontrictive dihydrobenzopyran derivatives
12/10/2003EP0628064B2 Photochromic naphthopyrans
12/10/2003CN1460678A Chrysanthemum total flavone resin purification method
12/10/2003CN1130365C Alpha-1 adrenergic compounds, drug composition containing same and their use
12/09/2003US6660871 Synthesis of 4H-chromene derivatives
12/09/2003US6660767 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof
12/09/2003US6660756 Protease inhibitors; sexual disorders
12/09/2003US6660752 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
12/09/2003CA2266318C Flavonol containing food supplements
12/04/2003WO2003099780A2 Luminogenic protease substrates
12/04/2003WO2003099762A1 Agents and methods for the treatment of disorders associated with oxidative stress
12/04/2003WO2003034989A3 α-HYDROXYARYLBUTANAMINE INHIBITORS OF ASPARTYL PROTEASE
12/04/2003WO2002058694A3 Method of treating hematologic tumors and cancers using beta lapachone
12/04/2003US20030225290 Production of dihydronepetalactone by hydrogenation of nepetalactone
12/04/2003US20030225158 Compounds that modulate PPAR activity and methods for their preparation
12/04/2003US20030225150 Method of using a COX-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia
12/04/2003US20030225074 E.g., 2-((4'-Methoxy(1,1'-biphenyl)-4-yl)sulfonyl)amino-4-hydroxy-5-((2 -thiazolyl)thio)-pentanoic Acid
12/04/2003US20030224966 Bicycle lactones, perfumery uses thereof, processes for preparing same and intermediates therefor
12/04/2003US20030224297 Chemically amplified resist, polymer for the chemically amplified resist, monomer for the polymer and method for transferring pattern to chemically amplified resist layer
12/04/2003CA2487273A1 Agents and methods for the treatment of disorders associated with oxidative stress
12/03/2003EP1367045A1 Intermediate products, methods for their preparation and use thereof
12/03/2003EP1366052A2 Novel multi-ring organic compounds for regulating gut motility and food intake
12/03/2003EP1366036A2 Compounds having activity as inhibitors of cytochrome p450rai
12/03/2003EP1366035A1 Preparation of warfarin sodium from warfarin sodium-2-propanol clathrate by solvent expulsion
12/03/2003EP0906366B1 Novel photochromic indeno-fused naphthopyrans
12/02/2003US6656485 Salified, water soluble bark extract; antiseptic properties
12/02/2003US6656358 Method for the chromatographic isolation of vitamin E isomers
12/02/2003CA2284446C New cyclic cycloalkylene chain derivatives, their preparation process and pharmaceutical compounds containing them
12/02/2003CA2249756C New indanol compounds, their preparation process and the pharmaceutical compositions containing them
11/2003
11/27/2003WO2003097765A1 Photochromic composition
11/27/2003WO2003097628A1 4-thio coumarins
11/27/2003WO2003097037A1 Allergic symptom reliever
11/27/2003WO2003096982A2 Substituted 4h-chromenes, 2h-chromenes, chromans and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/27/2003WO2003004091A3 Aromatic sulfenates for type i phototherapy
11/27/2003WO2002100813A3 Modulators of peroxisome proliferator activated receptors
11/27/2003US20030220397 Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
11/27/2003US20030220388 Indoline derivatives
11/27/2003US20030220338 Fungal efflux pump inhibitors
11/27/2003US20030220228 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
11/26/2003EP1364947A1 Preparation of isocoumarin derivatives and intermediates for the synthesis thereof
11/26/2003EP1363896A1 Synthesis of beta-lapachone and its intermediates
11/26/2003EP1363895A2 Process for the production of tocotrienols
11/26/2003EP1363894A1 Preparation of warfarin sodium from warfarin acid
11/26/2003EP1363893A1 Process for purification of warfarin acid, warfarin alkali metal salts and corresponding clathrates
11/26/2003EP1363880A1 Synthesis for the preparation of compounds for screening as potential tubulin binding agents
11/26/2003EP1363619A2 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof
11/26/2003EP1259523B1 Pluraflavins and derivatives thereof, process for their preparation and use thereof
11/26/2003EP1119559B1 3-phenyl-pyrones
11/26/2003EP1025096B1 Substituted chroman derivatives
11/26/2003EP1025095B1 Substituted chroman derivatives
11/26/2003EP1007528B1 Robustaflavone, intermediates and analogues and method for preparation thereof
11/25/2003US6653499 Photoisomerizable/dimerizable groups; liquid crystals displays
11/25/2003US6653488 Reacting a 3-aminopropionitrile with benzophenonecarboxylic acid; amidation
11/25/2003US6653472 Preparing amidines derived from 6-hydroxy-2,5,7,8-tetramethylchromane-2-carboxylic acid
11/25/2003US6653323 Aryl aniline β2 adrenergic receptor agonists
11/25/2003US6652877 With lipid or liposomal compounds
11/20/2003WO2003095442A2 Process for the preparation of 3-isochromanone
11/20/2003WO2003094910A1 Use of 8-prenylflavanones for anti-angiogenesis therapy and for fibrinolytic therapy
11/20/2003WO2003094878A1 Gallocatechin gallate-containing composition
11/20/2003WO2003037884A3 Process for separation of tocopherols
11/20/2003WO2003017946A3 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
11/20/2003WO2002041910A3 Methods and compositions for the treatment of diseases of the eye
11/20/2003US20030216586 Biaromatic compounds and pharmaceutical and cosmetic compositions comprising them
11/20/2003US20030216465 Anti-constipation composition
11/20/2003US20030216435 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
11/20/2003US20030216419 Isomeric fused pyrrolocarbazoles and isoindolones
11/20/2003US20030216389 Therapeutic morpholino-substituted compounds
11/20/2003CA2485114A1 Process for the preparation of 3-isochromanone
11/20/2003CA2484736A1 Gallocatechin gallate-containing composition
11/19/2003EP1196153B1 Process for the improvement of spermatozoa fertilization activity
11/19/2003EP1117628B1 2, 4-pentadienoic acid derivatives having selective activity for retinoid x (rxr) receptors
11/19/2003EP0756477B1 Methods for phototherapeutic treatment of proliferative skin diseases
11/19/2003CN1456559A Method for extracting soybean isoflavone
11/19/2003CN1456558A Method for extracting soybean isoflavone
1 ... 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 ... 242